Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Protoxin for Glabellar Lines
NCT06124794Phase 3Completed
- Sponsor
- Sophiris Bio Inc.
- Start
- Dec 2023
- Primary completion
- Feb 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of PROTOXIN in glabellar lines, sponsored by Sophiris Bio Inc.. Started Dec 2023; status: completed.
02
Drugs
PROTOXIN
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT06124794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06124794.